<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/650D4DCC-9DAD-4C30-B396-70658143D7A1"><gtr:id>650D4DCC-9DAD-4C30-B396-70658143D7A1</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Pinkoski</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U132688494"><gtr:id>01CC71EA-F47A-4387-8506-79978F7A4CFD</gtr:id><gtr:title>Cell death mechanisms in the peripheral immune system</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U132688494</gtr:grantReference><gtr:abstractText>The immune system lies at the interface with other physiological systems and its regulation has profound impact on physiological processes and related diseases. Generation, activity and maintenance of a functional immune system requires regulated cell death at every stage of lymphocyte selection, action and deletion. Our research is aimed at understanding general mechanisms of cell death and how respective mechanisms are utilized to mediate immune cell function and to regulate immune responses and homeostasis. In the immune system, the optimal death is one that results in complete and efficient removal of unwanted cells in a manner that elicits an appropriate immune response without collateral damage to surrounding cells/tissue. Our approach is one of an integrated program investigating general mechanisms of cell death and how those mechanisms are specifically applied in the immune system. We are using experimental models to investigate how molecular mechanisms of apoptosis are utilized in vivo in physiological systems and diseases such as immune surveillance, lymphoproliferative and autoimmune disorders, graft-versus-host disease and cancer chemotherapy. A major focus of our studies concerns the adverse drug reaction resulting in immune suppression during chemotherapy with genotoxic agents and how these off-target effects impact immune responses.</gtr:abstractText><gtr:technicalSummary>The immune system lies at the interface with other physiological systems and its regulation has profound impact on physiological processes and related diseases. Cellular cytotoxicity can be mediated by cytotoxic T lymphocytes during antigen-dependent and independent killing of virus-infected and tumour target cells. Interactions between peripheral lymphocytes and their nonlymphoid environment modulate lymphocyte deletion at the resolution of immune responses. Failure to do so is an underlying factor in the pathogenesis of lymphoproliferative and autoimmune disorders resulting from autoimmune tissue destruction. Similar cell death mechanisms in peripheral lymphocytes govern adverse drug reactions during chemotherapy which can cause immune suppression. These off-target effects have profound effects on immune responses and represent a serious clinical limitation.||I. Mechanisms of antigen-restricted apoptosis of target cells induced by CTL in vivo.|We are dissecting the components of CTL necessary to effect efficient clearance of target cells in vivo. Preliminary evidence suggests that not all CTL killing can be attributed to known pathways. We are utilizing in vivo cytotoxicity assays and transgenic/knock-out mouse lines to determine the contribution of each of the known pathways in CTL killing and investigate a major, previously unrecognized component of antigen-specific killing.||II. Mechanisms of genotoxicity in peripheral lymphocytes.|Many chemotherapeutic regimens involve drugs that act by inducing DNA damage in tumour cells. As a result of treatment, patients frequently experience a systemic immune suppression due to the coincidental killing of lymphocytes and/or thymocytes. Sensitivity to DNA damage induced apoptosis may reflect the immune systems preference to delete damaged lymphocytes rather than risk propagation of mutations in the peripheral reactive lymphocyte pool. Mechanisms governing normal peripheral lymphocyte deletion are similar to those leading to the profound effects on immune responses in patients receiving cancer chemotherapy.||The aims of this project are i) to investigate the molecular mechanisms of lymphocyte death following exposure to DNA damaging genotoxic insult; and ii) to study the impact on primary and secondary immune responses during immunosuppression in vivo due to exposure to genotoxic stress, such as that experienced during cancer chemotherapy or during treatment of autoimmune disorders. We are investigating the mechanisms of death in both normal resting lymphocytes (i.e. potentially leading to immunosuppression) and in T cell acute lymphoblastic leukemia (T-ALL) cell lines to gain a better understanding of chemotoxicity and potential target identification.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1261994</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>476D214A-1426-4C94-9F3F-64BFA5415A41</gtr:id><gtr:title>Phenylarsine oxide interferes with the death inducing signaling complex and inhibits tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6b5b320fef2f1f45ba3a8b56ca0de7"><gtr:id>4d6b5b320fef2f1f45ba3a8b56ca0de7</gtr:id><gtr:otherNames>Sun XM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn><gtr:outcomeId>F1C82557DA1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D305D48D-EBD3-414D-B1D2-33AB82233906</gtr:id><gtr:title>Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/532598b98b028a69feb3aaf7c4089099"><gtr:id>532598b98b028a69feb3aaf7c4089099</gtr:id><gtr:otherNames>Sayan AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>C3B4618F1D3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D31DBAC-41D3-498A-8CB5-7BB444918A15</gtr:id><gtr:title>Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/531f31c3acea31db910212a6fc05967e"><gtr:id>531f31c3acea31db910212a6fc05967e</gtr:id><gtr:otherNames>Kohlhaas SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>FFFD8B08EBF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5875C191-524D-4F4E-873E-9D257E1E5E81</gtr:id><gtr:title>Calreticulin: raising awareness of apoptosis.</gtr:title><gtr:parentPublicationTitle>Apoptosis : an international journal on programmed cell death</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ba9c4e4f4eb0310a81d12662893113d"><gtr:id>5ba9c4e4f4eb0310a81d12662893113d</gtr:id><gtr:otherNames>Waterhouse NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1360-8185</gtr:issn><gtr:outcomeId>730A0A92002</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U132688494</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>